# AbbVie Inc. (NYSE: ABBV), North Chicago, IL – FDA Inspections

Source: https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e

> Inspection records and compliance data for AbbVie Inc. in North Chicago, Illinois. 22 FDA inspections on record, 3 Form 483s, last inspected April 27, 2026. Publicly traded as NYSE: ABBV.

---

## Details

- Name: AbbVie Inc.
- FEI Number: 3009751352
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: 1 N Waukegan Rd
- City: North Chicago
- State: Illinois
- Zip Code: 60064
- Country Name: United States
- Address: 1 N Waukegan Rd, North Chicago, Illinois 60064, United States
- Country: United States

## Stock

- Stock ticker: ABBV
- Exchange: NYSE
- Share price: $294.48
- Market cap: $520.5B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1299008 - AbbVie Inc. - 2026-04-27 — source: FDA, date: April 27, 2026
- FDA Inspection 1302298 - AbbVie Inc. - 2026-04-02 — source: FDA, date: April 2, 2026
- FDA Inspection 1277010 - AbbVie Inc. - 2025-08-21 — source: FDA, date: August 21, 2025
- FDA Inspection 1277010 - AbbVie Inc. - 2025-08-21 — classification: No Action Indicated (NAI), source: FDA, date: August 21, 2025
- FDA Inspection 1257605 - AbbVie Inc. - 2025-06-12 — source: FDA, date: June 12, 2025
- [FDA Inspection 1257605 - AbbVie Inc. - 2025-06-12](https://www.keypedia.com/records/fda_inspections/abbvie-inc/d600c417-90fe-4fef-ae17-05d2b6b5bb8b) — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2025
- FDA Inspection 1230795 - AbbVie Inc. - 2025-02-18 — source: FDA, date: February 18, 2025
- FDA Inspection 1231413 - AbbVie Inc. - 2024-04-19 — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2024
- [483 - AbbVie Inc. - 2023-01-31](https://www.keypedia.com/records/483/abbvie-inc/51b48e1e-9723-4387-b252-4cc5015026fd) — source: FDA, date: January 31, 2023
- FDA Inspection 1198013 - AbbVie Inc. - 2023-01-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2023
- [FDA Inspection 1198013 - AbbVie Inc. - 2023-01-31](https://www.keypedia.com/records/fda_inspections/abbvie-inc/d2e8d086-0765-4436-8915-dc0a19feb201) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2023
- [EIR - AbbVie Inc. - 2021-12-15](https://www.keypedia.com/records/eir/abbvie-inc/4ea67f2c-2701-4a6c-b4a3-6225b781f7a3) — source: FDA, date: December 15, 2021
- [EIR - AbbVie Inc. - 2019-02-15](https://www.keypedia.com/records/eir/abbvie-inc/e854b1d5-8667-473b-aea4-d77c030613dc) — source: FDA, date: February 15, 2019
- [EIR - AbbVie Inc. - 2018-07-02](https://www.keypedia.com/records/eir/abbvie-inc/d5fd9956-7bc9-426d-8892-df6415f4b92b) — source: FDA, date: July 2, 2018
- [483 - AbbVie Inc. - 2018-07-02](https://www.keypedia.com/records/483/abbvie-inc/3b96cb46-4514-4018-a787-d89fad0a8d6f) — source: FDA, date: July 2, 2018
- [EIR - AbbVie Inc. - 2017-12-15](https://www.keypedia.com/records/eir/abbvie-inc/670afc69-446b-472a-b6de-83d020c0613a) — source: FDA, date: December 15, 2017
- [483 - AbbVie Inc. - 2017-12-15](https://www.keypedia.com/records/483/abbvie-inc/0596cbbe-5bd3-4926-bb9d-5e5d61b58ba4) — source: FDA, date: December 15, 2017

## Related Companies

- [Renaissance Lakewood, LLC](https://www.keypedia.com/companies/renaissance-lakewood-llc/8b2036d4-96e6-4cb1-84fc-6baf5111e9f7)
- [Corden Pharma S.p.A.](https://www.keypedia.com/companies/corden-pharma-spa/9ebac113-b666-42f4-bce9-0183154975f3)
- [Catalent CTS, LLC](https://www.keypedia.com/companies/catalent-cts-llc/db17ec22-68a4-42be-86e9-4c1410a493a8)
- [Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.](https://www.keypedia.com/companies/gregory-pharmaceutical-holdings-inc-dba-upm-pharmaceuticals-inc/abed0e84-484c-4ab7-b062-f61cc359a27e)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/6b5864ed-07a2-4861-b424-021018d4f7e9)
- [Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg-ravensburg-mooswiesen/d0287c3d-c544-40de-aece-ba713025286c)
- [Tris Pharma Inc.](https://www.keypedia.com/companies/tris-pharma-inc/65a6590a-3777-454b-bf0d-a9d37e3bf58e)
- [Rottendorf Pharma Gmbh](https://www.keypedia.com/companies/rottendorf-pharma-gmbh/e63a13cc-bb19-4b83-9c26-200b73395eb1)
- [Ferring Production Inc.](https://www.keypedia.com/companies/ferring-production-inc/630420f9-f163-4b8d-91f5-d4922708508e)
- [Cenexi](https://www.keypedia.com/companies/cenexi/14746111-88b0-4fb3-9892-19407224ae9e)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michele-perry-williams/80741e95-8df3-41c9-b9b8-499fcb97921d)
- [Investigator?](https://www.keypedia.com/people/robert-j-ham/9146e819-4fce-420c-a722-cbe14e3c6afb)
- [company_representative](https://www.keypedia.com/people/chad-ballard/27b6f31e-3b1d-468e-936d-fc531e8d3bf4)
- [company_representative](https://www.keypedia.com/people/scott-page/33111b5b-0fb4-4def-b3b2-2fe5e22a9168)
- [Vice President](https://www.keypedia.com/people/vicki-r-edwards/05433d7f-c420-4bc2-988b-7029e04ff6be)
- [Quality Program Specialist/Program Analyst](https://www.keypedia.com/people/lequita-mayhew/7c553294-3678-4771-acb4-92c4b8fbc0b1)